Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

  • This share is currently suspended. It was suspended at a price of 650.00
  • There is currently no data for HAT

Form 8.3 - H&T Group plc

21 Jul 2025 15:25

RNS Number : 7534R
Glazer Capital, LLC
21 July 2025
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Glazer Capital, LLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

H&T Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

July 18, 2025

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

734,615

1.67%

 

 

(2) Derivatives (other than options):

 

 

(3) Options and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

734,615

1.67%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

5p ordinary

Purchase

50,000

6.39 GBP

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

July 21, 2025

Contact name:

Anny Kim

Telephone number:

212-804-9971

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSFFFUAEISEDW
Date   Source Headline
11th Aug 20207:00 amRNSUNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS
22nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20204:35 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSH&T appoints Chris Gillespie as executive director
29th Jun 20207:00 amRNSCOVID-19 update
23rd Jun 20201:36 pmRNSNotification of major holdings
11th Jun 20208:44 amRNSNotice of Annual Report Posting
18th May 20207:00 amRNSAGM Results
23rd Apr 20207:00 amRNSDirector Dealings and Issue of Equity
6th Apr 20207:00 amRNSCOVID-19 Update
18th Mar 20204:36 pmRNSPrice Monitoring Extension
10th Mar 20207:00 amRNSAnnual Financial Report
27th Jan 20207:00 amRNSTrading Update and Notice of Results
14th Jan 20207:00 amRNSBoard changes
19th Nov 201912:39 pmRNSNotification of major holdings
18th Nov 20197:00 amRNSFCA review
8th Nov 20194:40 pmRNSSecond Price Monitoring Extn
8th Nov 20194:35 pmRNSPrice Monitoring Extension
7th Nov 20194:40 pmRNSSecond Price Monitoring Extn
7th Nov 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20191:28 pmRNSAdditional Listing
30th Sep 20194:43 pmRNSAcquisition & Trading
18th Sep 20197:00 amRNSExecutive Director
5th Sep 20193:39 pmRNSAdditional Listing
13th Aug 20197:00 amRNSUnaudited Interim Condensed Financial Statements
7th Aug 20192:00 pmRNSNotice of Results
22nd Jul 20193:42 pmRNSFinancial Director
22nd Jul 201911:15 amRNSStephen Fenerty
12th Jul 20191:59 pmRNSNotification of Major Holdings
5th Jul 20195:39 pmRNSNotification of Major Holdings
2nd Jul 20197:00 amRNSResult of Placing
1st Jul 20194:35 pmRNSAcquisition and Placing
21st Jun 20197:00 amRNSNotice of Annual Report Posting
3rd May 20197:00 amRNSResult of AGM
23rd Apr 20197:00 amRNSAdditional Listing
4th Apr 20194:00 pmRNSDirector dealings and issue of equity
12th Mar 20197:00 amRNSPreliminary Results
23rd Jan 20197:00 amRNSTrading Update and Notice of Results
3rd Jan 20197:00 amRNSPerformance Share Plan Awards
21st Nov 20184:21 pmRNSNotification of Major Holdings
10th Oct 201812:00 pmRNSNotification of Major Holdings
11th Sep 20187:00 amRNSDirector/PDMR Shareholding
14th Aug 20187:00 amRNSInterim Results
27th Jul 20184:23 pmRNSIFRS 9 Transition Document
16th Jul 20184:18 pmRNSNotification of Major Holdings
20th Jun 201810:25 amRNSAdditional Listing
14th Jun 20185:32 pmRNSDirector Dealings
13th Jun 201812:19 pmRNSDirector Dealings
29th May 20184:14 pmRNSNotification of Major Holdings
29th May 20187:00 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.